DarioHealth (DRIO) Net Equity Issued and Repurchased (2013 - 2022)

DarioHealth's Net Equity Issued and Repurchased history runs 5 years deep, the most recent figure standing at $265000.0 for Q4 2022.

• Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $265000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $38.3 million (down 40.98% YoY) and the FY2022 annual result came in at $38.3 million, down 40.98% from the prior year.
• Net Equity Issued and Repurchased was $265000.0 for Q4 2022 at DarioHealth, down from $38.0 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $64.9 million in Q1 2021 and bottomed at $265000.0 in Q4 2022.
• A 4-year average of $29.9 million and a median of $27.5 million in 2020 frame the typical range for Net Equity Issued and Repurchased.
• Peak annual rise in Net Equity Issued and Repurchased reached 41.39% in 2022, while the deepest fall reached 41.39% in 2022.
• DarioHealth's Net Equity Issued and Repurchased stood at $18.7 million in 2019, then soared by 47.4% to $27.5 million in 2020, then surged by 135.51% to $64.9 million in 2021, then tumbled by 99.59% to $265000.0 in 2022.
• Business Quant data shows DRIO's Net Equity Issued and Repurchased at $265000.0 in Q4 2022, $38.0 million in Q1 2022, and $64.9 million in Q1 2021.